Altria Group remains a United States nicotine cash engine whose second quarter tests whether cigarette pricing still funds a smoke-free transition that has not yet replaced the profit base. Sal Mancuso took over as chief executive in May after Billy Gifford retired, and the first full print under Mancuso and chief financial officer Heather Newman raised the low end of full-year adjusted earnings guidance. Smokeable products still produce almost all of the operating profit. The smoke-free story is visible in stores and still thin on the income statement.
Helix pushed on! PLUS across a national store base and spent oral-tobacco profit to do it. Oral adjusted operating companies income fell 8.0 percent even as on! retail share of the oral category reached 8.6 percent. Cigarette volume kept shrinking, yet smokeable adjusted operating companies income still rose because Philip Morris USA lifted price and collected import-tax refunds. Marlboro gave up total-category share as the industry discount mix widened. The brand held its grip on the premium tier. That is the actual machine: harvest the cigarette franchise, spend a slice of oral profit to stay in pouches, and keep the dividend flowing.
The company raised the floor of full-year adjusted diluted earnings guidance to a band of $5.61 to $5.72. First-half adjusted diluted earnings grew 4.9 percent. Cash returned to shareholders was dominated by the regular dividend rather than the buyback. The open question for the next several quarters is whether on! PLUS can convert store presence into oral-category profit while NJOY ACE stays off the United States market under the International Trade Commission exclusion order.